September 26, 2019
Myelodysplastic syndrome (MDS), one of the most common blood cancers, has very few treatment options. Now, researchers at Cold Spring Harbor Laboratory (CSHL) have discovered a new and promising drug target for this deadly condition. “At the moment, only a small portion of patients benefit from the standard therapy for […]